• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chem Biol Interact . Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro

tetano

Editor, Senior Moderator
Chem Biol Interact


. 2022 Mar 21;109898.
doi: 10.1016/j.cbi.2022.109898. Online ahead of print.
Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora


Khalid Saad Alharbi[SUP] 1 [/SUP], Yogendra Singh[SUP] 2 [/SUP], Waleed Hassan Almalki[SUP] 3 [/SUP], Sushama Rawat[SUP] 4 [/SUP], Obaid Afzal[SUP] 5 [/SUP], Abdulmalik Saleh Alfawaz Altamimi[SUP] 5 [/SUP], Imran Kazmi[SUP] 6 [/SUP], Fahad A Al-Abbasi[SUP] 6 [/SUP], Sami I Alzarea[SUP] 1 [/SUP], Sachin Kumar Singh[SUP] 7 [/SUP], Shvetank Bhatt[SUP] 8 [/SUP], Dinesh Kumar Chellappan[SUP] 9 [/SUP], Kamal Dua[SUP] 10 [/SUP], Gaurav Gupta[SUP] 11 [/SUP]



Affiliations

Abstract

Coronavirus disease (COVID-19), a coronavirus-induced illness attributed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, is thought to have first emerged on November 17, 2019. According to World Health Organization (WHO). COVID-19 has been linked to 379,223,560 documented occurrences and 5,693,245 fatalities globally as of 1st Feb 2022. Influenza A virus that has also been discovered diarrhea and gastrointestinal discomfort was found in the infected person, highlighting the need of monitoring them for gastro intestinal tract (GIT) symptoms regardless of whether the sickness is respiration related. The majority of the microbiome in the intestines is Firmicutes and Bacteroidetes, while Bacteroidetes, Proteobacteria, and Firmicutes are found in the lungs. Although most people overcome SARS-CoV-2 infections, many people continue to have symptoms months after the original sickness, called Long-COVID or Post COVID. The term "post-COVID-19 symptoms" refers to those that occur with or after COVID-19 and last for more than 12 weeks (long-COVID-19). The possible understanding of biological components such as inflammatory, immunological, metabolic activity biomarkers in peripheral blood is needed to evaluate the study. Therefore, this article aims to review the informative data that supports the idea underlying the disruption mechanisms of the microbiome of the gastrointestinal tract in the acute COVID-19 or post-COVID-mediated elevation of severity biomarkers.

Keywords: Bacteroides species; Inflammatory cytokines; Lectin RegIII beta; Microbiota; SARS-CoV-2.
 
Back
Top Bottom